Infection and Immunity, June 1999, p. 2815-2821, Vol. 67, No. 6
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Evaluation of Salmonella typhimurium
Mutants in a Model of Experimental Gastroenteritis
Paul
Everest,1,*
Julian
Ketley,2
Simon
Hardy,3
Gill
Douce,1,
Shahid
Khan,4
Jacqui
Shea,5
David
Holden,5
Duncan
Maskell,4 and
Gordon
Dougan1
Department of Biochemistry, Imperial College of Science,
Technology and Medicine,1 and Department
of Infectious Diseases, Imperial College School of Medicine,
Hammersmith Hospital,5 London;
Department of Genetics, University of Leicester,
Leicester2; Department of Pharmacy,
University of Brighton, Brighton3; and
Department of Clinical Veterinary Medicine, University of
Cambridge Veterinary School, Cambridge,4 United
Kingdom
Received 23 October 1998/Returned for modification 21 December
1998/Accepted 5 March 1999
 |
ABSTRACT |
Salmonella typhimurium strains harboring independent,
defined mutations in aroA, invA,
ssrA, or msbB were assessed for their ability
to induce fluid accumulation, tissue damage, and local inflammation in
rabbit ileal loops. Three wild-type strains of S. typhimurium, TML, HWSH, and SL1344, and two mutant strains, S. typhimurium SL1344 ssrA and S. typhimurium SL1344 msbB, consistently induced fluid
accumulation in the lumen of loops and inflammation of loop-associated
tissues. In contrast, three different S. typhimurium aroA
strains and an invA mutant of SL1344 did not induce
significant fluid accumulation in the rabbit ileal loops. However, the
S. typhimurium aroA strains did induce an inflammatory
infiltrate and some local villus-associated damage, but the
invA mutant did not. Histologically, wild-type S. typhimurium, S. typhimurium SL1344 ssrA,
and S. typhimurium SL1344 msbB demonstrated
more severe effects on villus architecture than S. typhimurium
aroA strains, whereas S. typhimurium invA-infected
loops showed no detectable damage. This suggests that villus damage
most likely contributes to fluid accumulation within the loop.
 |
INTRODUCTION |
Salmonella-associated
infections can be grouped into two general types according to their
clinical features and underlying pathogenicities
(18). Isolates of most Salmonella enterica
serovars cause localized enteric infections or gastroenteritis
associated with diarrhea and abdominal pain during which the infecting
salmonella bacteria invade the gut wall but remain predominantly
associated with the gut tissue and local lymphatics. These
Salmonella serotypes can sometimes spread systemically
in very old, very young, or immunocompromised individuals.
Other organisms in the genus Salmonella, including
S. enterica serovar Typhi (S. typhi), cause systemic diseases, including typhoid, in which
bacteria spread to organs of the reticuloendothelial system,
including the liver and spleen (20, 21).
Salmonella is an attractive target organism for scientific
investigators interested in the genetic basis of virulence. In particular, the availability of excellent genetic manipulation techniques and the murine model of infection has allowed a huge amount
of work to be performed. However, the ready accessibility of mice
has also resulted in most in vivo studies of salmonella virulence
being carried out in this model. Mouse-virulent
Salmonella strains cause a systemic disease in mice that
superficially resembles human typhoid (5, 6). In this
model, mice do not develop diarrhea but do succumb to
overwhelming bacterial growth in deep tissues. With the murine
model, many Salmonella genes have been shown to contribute
to virulence (7). The identification of attenuating
mutations has encouraged the development of novel live salmonella
vaccine strains (2, 5-7, 16, 17, 19, 24, 28, 32-35). Most
work toward developing this vaccine for humans has involved attempts to
develop live oral typhoid vaccines based on genetically defined
S. typhi (17).
Identification of candidate attenuating mutations for use in
experimental typhoid vaccines has been, in large part, dependent on
studies of Salmonella typhimurium in the mouse, as S. typhi isolates exhibit low virulence rates in nonhumans. Few
attenuated mutants identified in the mouse have been examined for their
role in the diarrhea associated with Salmonella infections,
as the mouse model is inappropriate for this purpose. Many of the
virulence-associated genes identified by using the murine model fall
into distinct classes. Some encode enzymes for critical biosynthetic
pathways essential to sustain in vivo growth, such as the
aro genes, which encode enzymes of the chorismate pathway
(16, 17). Some encode type III secretion systems and are
known as pathogenicity islands. Salmonella spp. have at
least two such loci. One, named Salmonella pathogenicity
island 1 (SPI-1), contributes to eucaryotic cell invasion (8, 22,
25, 26). A second, SPI-2, contributes to survival in deep tissue
(29). Another group of genes are involved in the
biosynthesis of lipopolysaccharide. For example, msbB is
involved in the biosynthesis of the highly toxic lipid A component of
lipopolysaccharide, and S. typhimurium msbB mutants have an
altered pathogenicity in the mouse and a reduced ability to induce
production of tumor necrosis factor alpha, interleukin 1, and nitric
oxide (23).
In contrast to studies of systemic disease, investigations of the
contributions of different Salmonella genes to
gastroenteritis and diarrhea are more difficult to undertake because of
the lack of readily available experimental systems. The rabbit loop
model has been utilized as a method for identifying
Salmonella strains that are able to induce fluid
accumulation and potentially diarrhea (3, 12, 13, 15, 30,
36, 37, 40). For example, S. typhimurium
TML has been shown to be a strong inducer of fluid accumulation and
associated pathology in this model (12, 37). We employed the
rabbit ileal loop assay to investigate the contributions of different
classes of virulence-associated S. typhimurium genes, previously characterized in the murine model, to the
pathogenesis of gastroenteritis and diarrhea.
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
S.
typhimurium TML was isolated from a clinical case of human
gastroenteritis, causes diarrhea in monkeys, and has been shown in
previous studies to invade rabbit ileal loop mucosa and cause an
intense inflammatory response and fluid accumulation within 18 h
(10-14, 30, 31, 36, 37). S. typhimurium TML
aroA was provided by G. Douce (Imperial College, London,
United Kingdom). S. typhimurium HWSH was initially isolated
from a calf dying of systemic salmonellosis (27). S. typhimurium HWSH aroA harbors a deletion mutant in the
aroA gene and has been described previously (27).
S. typhimurium SL1344 and SL1344 aroA (strain
3261) have been described previously (15). S. typhimurium SL1344 msbB was constructed by inserting a
DNA sequence encoding kanamycin resistance into a cloned S. typhimurium msbB gene and replacing the wild-type msbB
gene with the inactivated gene by allelic exchange (23). S. typhimurium SL1344 ssrA is defective in
expression of the type III secretion system encoded within SPI-2.
S. typhimurium SL1344 invA was provided by Tahir
Ali (Imperial College). S. typhimurium SL1344
invA is defective in the expression of SPI-1 (9)
(Table 1).
Bacteria were grown statically and aerobically in Luria broth overnight
at 37°C. For intestinal infection, bacteria were harvested by
centrifugation and resuspended at a concentration of 108
bacteria/ml in phosphate-buffered saline (PBS) for injection into
rabbit ileal loops.
Ileal loop procedure.
Specific-pathogen-free New Zealand
White rabbits weighing less than 2 kg were anesthetized. The peritoneal
cavity was opened by a sterile surgical technique, and the bowel was
carefully washed with prewarmed PBS and clamped at least 20 cm distal
to the ligament of Trietz. The required number of loops (loop length, 5 cm; interloop length, 5 cm) was measured, and the bowel was clamped
proximal to the ileo-cecal junction. The length of bowel making the
loops was cut at both ends, and all cut surfaces were clamped. The
remaining intestine was reanastomosed and placed back into the
peritoneal cavity. The resected ends of the isolated intestine were
closed with sutures, and, to avoid compromising the integrity of blood supply to the tissue, the required number of loops was constructed by
tying with ligatures. While closing the loop tie, we injected the
bacterial suspension containing approximately 108 viable
bacteria in a 0.5-ml volume of PBS into the proximal end of the loop.
Positive-control loops were inoculated with 1 µg of cholera toxin
(CT) (a gift from M.-G. Pizza, Instituto Richerche Immunologique Siena,
Siena, Italy) in 0.5 ml of PBS; negative-control loops received 0.5 ml
of PBS alone. The resected intestine was replaced into the peritoneal
cavity, the cavity was closed, and the animal was allowed to recover.
After 18 h, the animal was anesthetized, and the loops were
removed and weighed, and loop fluids were placed in sterile containers.
Analysis of fluids from loops.
Fluid from infected loops was
measured by volume, and the consistency, in terms of color
and viscosity, was noted. Bacterial and cellular contents (erythrocytes
and leukocytes) of the fluid were determined by wet preparation and
Gram and Giemsa staining. The predominant cell types in the fluid
exudate were determined by differential counts after Giemsa staining.
Loop fluids were centrifuged to remove cellular components and
assayed for bicarbonate, pH, and hemoglobin levels with a laboratory
biochemical analyzer (Radiometer, Copenhagen, Denmark) and for total
protein by the method of Bradford (1).
Histopathology of intestinal tissue.
After postmortem
removal, the loop tissue was weighed and cut longitudinally to release
any fluid contained within. Any gross changes were noted, and the
mucosal side was inspected for macroscopic tissue damage. Loop tissue
was washed in PBS, and small samples of loop tissue were placed into
10% formaldehyde in PBS at pH 7.2. Tissue was wax embedded, and
thin-cut sections were stained with hematoxylin and eosin and examined
under bright-field illumination with a Nikon Axiophot microscope.
Quantitation of bacteria in loops and fluids.
Loop fluid was
assessed for number of viable bacteria by dilution and surface-viable
counting by using a modification of the technique of Miles et al.
(25). Loop tissue samples taken post mortem were cultured
for S. typhimurium to demonstrate the presence of bacteria
on or within loop tissue. Tissue samples (0.5 g [wet weight]) were
washed with PBS before homogenization. Tissue was homogenized in 5 ml
of Luria broth in a stomacher, and the resulting suspension was
serially diluted for surface viable counting. All samples were
plated on Luria agar.
 |
RESULTS |
Fluid secretion in rabbit ileal loops induced by different
wild-type S. typhimurium strains and their mutant
derivatives.
Different S. typhimurium mutant
derivatives and the appropriate S. typhimurium wild-type
controls were inoculated into ligated rabbit ileal loops, and the level
of fluid accumulation over the next several hours was noted. Wild-type
S. typhimurium TML, HWSH, and SL1344 consistently caused
significant levels of fluid to accumulate within the gut lumen
compared to uninfected control loops. The loop-derived fluid was
blood stained and, when examined microscopically, found to contain
many erythrocytes and polymorphonuclear leukocytes (PMNs).
Fluid taken from loops infected with S. typhimurium HWSH
contained blood clots which were not detectable in similar loops
infected with other Salmonella strains. The volumes of
fluids varied between 3 and 6 ml for the inoculations of different
wild-type strains (Fig. 1). Loops
infected with SL1344 ssrA or SL1344 msbB were
macroscopically indistinguishable from loops infected with wild-type
S. typhimurium controls. In contrast, the S. typhimurium aroA mutants and S. typhimurium SL1344
invA failed to induce any significant fluid accumulation.
However, on the apical, lumen-exposed surface of loops infected
with S. typhimurium aroA derivatives, a thin layer of pus
was consistently associated with the mucosal surface, which, upon
microscopic examination, was shown to be composed mainly of sheets of
PMNs. Interestingly, this thin layer of pus was not observed when
the invA mutant was tested. The increase in tissue weights
for the wild-type S. typhimurium-infected
loops reflected the fluid contained within them (Fig.
2).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Volumes of fluid recovered from infected rabbit ileal
loops 18 h after infection. (a) Fluid recovery in control loops
inoculated with either CT as a positive control or PBS as a negative
control. (b) Fluid accumulation in loops immunized with wild type
S. typhimurium strain TML, HWSH, or SL1344 or the equivalent
aroA mutant. (c) Fluid accumulation in loops inoculated with
S. typhimurium in which deletions have been engineered in
the msbB, invA, or ssrA gene. These
mutants were all created in wild-type S. typhimurium SL1344,
which is included for comparison. Error bars represent standard errors
of the means. WT, wild type.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Weight of infected loops recovered from animals 18 h after infection. (a) Weight of control loops inoculated with either
CT as a positive control or PBS as a negative control. (b) Weight of
loops immunized with wild-type S. typhimurium strain TML,
HWSH, or SL1344 or the equivalent aroA mutant. (c) Weight of
loops inoculated with S. typhimurium msbB, invA,
or ssrA. These mutants were all created in wild-type
S. typhimurium SL1344, which is included for comparison.
Error bars represent standard deviations. WT, wild type.
|
|
Control loops injected with CT contained an average of 20 ml of
non-blood-stained fluid, and leukocytes were absent from these fluids.
Loops injected with PBS contained no free fluid.
Histopathology of rabbit ileal loops infected with different
S. typhimurium wild-type strains, S. typhimurium SL1344 msbB, and S. typhimurium SL1344 ssrA.
Tissue was taken from all
loops and studied for histological changes. Normal tissue taken
from a loop inoculated with PBS is shown in Fig.
3A.
Contrasting tissue taken from a loop
infected with wild-type HWSH is shown in Fig. 3B. The changes shown are typical of the histological changes observed in all loops infected with
the wild-type strains. In all cases, villi were shortened, and in some
cases villi were completely absent in tissue samples taken from loops
infected with any of the S. typhimurium wild-type strains
(Fig. 3C and E). There were large infiltrates of PMNs present in
the damaged villus structure of the lamina propria and on the
luminal surface of the mucosa. The lamina propria and submucosal
blood vessels also contained large numbers of infiltrating PMNs. The
villus enterocyte layer was severely damaged. There was bleeding into
the submucosa and free blood in the lumen. Tissue edema was evident,
unlike in PBS-injected controls (Fig. 3A). Loops infected with
wild-type S. typhimurium exhibited dilatation of the
crypts, suggesting an active secretory response to infection. Tissue taken from loops infected with either SL1344 ssrA or
SL1344 msbB (Fig. 3D) showed morphological changes identical
to those observed in loops infected with the appropriate wild-type
control.


View larger version (333K):
[in this window]
[in a new window]
|
FIG. 3.
Histological sections showing cross sections
(magnification, ×40) of loop-associated tissues stained with
hematoxylin and eosin. (A) Uninfected loop showing normal villus
height. (B) Loop infected with wild-type S. typhimurium
HWSH. Large numbers of inflammatory cells are highlighted in the lamina
propria (small arrow) and on top of damaged villi in the lumen (small
arrow). Dilation of the crypts suggests an active secretory response
(large arrow). Identical histology was also observed with wild-type
strains TML and SL1344. (C) Loop infected with S. typhimurium SL1344 showing large numbers of inflammatory cells
(arrow), predominantly neutrophils (architecture as described above).
(D) Loop infected with S. typhimurium SL1344
msbB. Histological changes were consistent with those
described above for tissues infected with wild-type strains. Similar
effects were observed with S. typhimurium SL1344
ssrA. (E) Loop infected with S. typhimurium TML.
There is extensive villus damage and a large number of inflammatory
cells in the lamina propria (arrow). (F) Loop infected with S. typhimurium TML aroA. Villus shortening and
architectural damage are less severe than in panel E, and significantly
less crypt dilation is apparent. Tissue taken from loops infected
with either SL1344 aroA or HWSH aroA
displayed identical histology. (G) Submucosal loop infected
with S. typhimurium SL1344 invA.
|
|
Histopathology of rabbit ileal loops infected with S. typhimurium invA and the different S. typhimurium
aroA mutants.
Intestinal tissue infected with S. typhimurium aroA strains exhibited some histopathological
similarities to intestinal tissue infected with wild-type S. typhimurium (Fig. 3E and F). However, there was a discernible
difference in the degree of tissue damage to the villi. The
villus structures were shortened but retained reasonable tissue
architecture, unlike the flattened mucosa exhibited after wild-type
S. typhimurium infection. Large numbers of PMNs were
present within the lamina propria of S. typhimurium
aroA-infected tissue, demonstrating an ongoing inflammatory
response. Loops infected with S. typhimurium aroA strains
showed significantly less crypt dilatation than wild-type-infected
tissue. No loops infected with S. typhimurium invA showed
significant and reproducible differences from uninfected control loops
(Fig. 3G).
Analysis of fluid from rabbit ileal loops.
The fluids
collected from loops infected with different S. typhimurium
derivatives were subjected to biochemical analysis (Table
2). The total protein content of the
fluid was high, reflecting the increased cellular content and,
presumably, leakage of plasma proteins from damaged capillaries, in
contrast to the secretory nature of the fluid from CT-treated loops.
There was also a high hemoglobin content in the fluid, reflecting the
visible presence of blood. Bicarbonate concentrations in the fluids
from S. typhimurium-infected tissue were within the normal
range for rabbit blood (16.2 to 31.8 mM). Fluid pH ranged from 4.5 to
5.2, in contrast to the alkaline pH of 8 in CT-induced fluid,
reflecting the high bicarbonate levels in the CT-induced fluids.
Microbiological analysis of infected rabbit ileal loops.
There
were large numbers of wild-type and mutant S. typhimurium
strains within all loops where fluid accumulation occurred (Fig.
4). Further, viable S. typhimurium strains could be recovered from homogenized intestinal
mucosa from all infected loops (Fig. 5).
The numbers of S. typhimurium mutants and wild-type controls present in the tissues were similar in all cases, with the exception of
the S. typhimurium invA mutant. Counts of these bacteria
from infected loops were significantly below those of the corresponding wild-type S. typhimurium control.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 4.
S. typhimurium viable counts in fluid
recovered from ileal loops. (a) PBS control. (b) Viable count of
bacteria in the fluid recovered from loops infected with one of three
wild-type S. typhimurium strains: TML, HWSH, or SL1344. (c)
Viable count of bacteria in the fluid recovered from loops infected
with S. typhimurium msbB, invA, or
ssrA. These mutants were all created in wild-type S. typhimurium SL1344, which is included for comparison. Error bars
represent standard deviations. WT, wild type.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 5.
S. typhimurium viable counts from infected
ileal loop tissue homogenates. (a) PBS control loop was not
cross-infected by S. typhimurium during the course of the
experiment. (b) Viable count of bacteria in loops infected with
wild-type S. typhimurium strain TML, HWSH, or SL1344 or the
equivalent aroA mutant. (c) Viable count of bacteria in
loops infected with S. typhimurium msbB, invA, or
ssrA. These mutants were all created in wild-type S. typhimurium SL1344, which is included for comparison. Error bars
represent standard deviations. WT, wild type.
|
|
 |
DISCUSSION |
Here we demonstrate that genes associated with S. typhimurium virulence in the murine model of typhoid fever show
significant differences in their influences on S. typhimurium virulence in the rabbit ileal loop model of
gastroenteritis. Wild-type strains of S. typhimurium SL1344, TML, and HWSH and mutants SL1344
ssrA and SL1344 msbB exhibited similar
patterns of pathogenicity in the rabbit ileum with respect to
levels of fluid secretion, histological damage, inflammation intensity,
and PMN infiltration. These data suggest that SPI-2 and a fully toxic
lipid A component of endotoxin are not required for the
induction of fluid accumulation in this model. Further, these
data indicate that these genes are not essential for the induction of
diarrhea in gastroenteritis. In contrast, S. typhimurium TML
aroA, HWSH aroA, and SL1344 aroA each
induced significant tissue inflammation but no significant fluid
accumulation. In addition, S. typhimurium SL1344
invA was found to be essentially avirulent in this assay,
inducing no significant fluid accumulation or tissue damage, which is
in agreement with published studies showing that SPI-1 function is
required for fluid secretion and tissue inflammation in calf
ileal loops (38, 39).
Giannella et al. and Gots et al. (11-15) observed a close
correlation between fluid secretion in rabbit ileal loops and the virulence for humans of gastroenteritis-causing S. typhimurium. Stephen et al. (4, 30, 31, 36, 37) showed
that strains of S. typhimurium in the rabbit ileal loop
model could be separated into three different groups: invasive and
diarrheagenic, invasive and nondiarrheagenic, and noninvasive and
nondiarrheagenic. Strains SL1027 and LT-7 were invasive but
nondiarrheagenic and failed to cause a net secretion of chloride in
Ussing chambers. This is in contrast to strains isolated from cases of
human gastroenteritis, including S. typhimurium TML
(30), which were found to be invasive in the rabbit ileal
loop, to cause fluid secretion, and to induce chloride secretion and
depressed sodium absorption in Ussing chambers. S. typhimurium TML was also shown to cause cell damage at villus tips
and to induce a large influx of PMNs into the mucosa. Structural damage
to villus tips led to shortened villi, which were suspected to
contribute to diarrhea by altering absorption/secretion ratios (30, 31). Fluid secretion in rabbit loops infected with
wild-type S. typhimurium was not observed in the absence of
leukocytes, but this leukocyte influx, by itself, did not induce fluid
secretion (36, 37).
Fluid accumulation induced by wild-type S. typhimurium was
associated with damaged and shortened villi. Although S. typhimurium infection had reduced the villi to almost flattened
mucosa by 18 h, most villi retained their structural integrity
during S. typhimurium aroA infection, although some
shortened villi were detectable. Both S. typhimurium wild
type and aroA derivatives induced large influxes of PMNs
into the submucosal tissue and lamina propria and onto the surface of
the mucosa. Thus, S. typhimurium aroA derivatives behave
like the invasive, non-fluid-accumulating strains described by Stephen
et al. (30). Loops infected with S. typhimurium
invA, which is poorly invasive in tissue culture cells, had
normal-looking villi and no inflammatory infiltrate, whereas S. typhimurium SL1344 ssrA, required for virulence beyond the mucosa in mice, was not impaired in its ability to induce infiltration and damage.
Thus, these data indicate that the main determinant of fluid
accumulation within the rabbit ileal loop could be invasion-induced damage to the villus structure. Wallis et al. (37), after
performing ileal loop experiments in cattle, proposed that villus
height reduction resulted in the loss of the upper absorptive region of
the villus, which in turn led to physiological secretion. They also
proposed that the regeneration of damaged villi could give rise to
hypersecretion. This is not observed in the S. typhimurium aroA-infected loops, as villus damage is apparently not severe enough to reduce the absorptive capability of the ileum or elicit hypersecretion due to villus regeneration. The other main histological difference observed in our study was that in ileal tissue infected with
wild-type S. typhimurium, the crypts were markedly dilated compared to the crypts in S. typhimurium aroA-infected
tissue, where no crypt dilation was observed. In view of the fact that fluid accumulation was observed only in wild-type S. typhimurium-infected loops, crypt secretion may be another
contributor to fluid accumulation in this model. The fact that S. typhimurium aroA derivatives failed to induce fluid accumulation
may be due to the large PMN infiltrate within the tissues controlling
infection before more extensive villus damage can occur.
One aim of this study was to determine which mutations might be
incorporated into candidate live oral S. typhimurium vaccine strains suitable for use in humans. It is essential that any candidate live vaccine be incapable of causing diarrhea. By using the rabbit ileal loop, we have demonstrated that the aroA and
invA (SPI-1) mutations are appropriate candidate genes for
this purpose, whereas in this assay ssrA (SPI-2) and
msbB gave no evidence of producing an attenuating effect.
The inability of S. typhimurium invA mutants to induce local
inflammation may suggest that they are poorly immunogenic, but this can
only be evaluated properly in volunteer studies.
 |
ACKNOWLEDGMENTS |
We acknowledge the technical support and advice of the Biomedical
Services staff at Leicester University.
G.D. and P.E. were supported by a program grant from the Wellcome
Trust. J.K. was a Royal Society University Research Fellow at the
University of Leicester. S.H. acknowledges support from the Wellcome
Trust (047407/Z/96).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Infectious Diseases, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom. Phone: 441813832067. Fax:
441813832074. E-mail: p.everest{at}ic.ac.uk.
Present address: Vaccine Research Unit, Medeva Development,
Imperial College, London, United Kingdom.
Editor:
P. E. Orndorff
 |
REFERENCES |
| 1.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[Medline].
|
| 2.
|
Chatfield, S. N.,
K. Strahan,
D. Pickard,
I. G. Charles,
C. E. Hormaeche, and G. Dougan.
1992.
Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model.
Microb. Pathog.
12:145-151[Medline].
|
| 3.
|
Chopra, A. K.,
C. W. Houston,
J. W. Peterson,
R. Prasad, and J. J. Mekalanos.
1987.
Cloning and expression of the Salmonella enterotoxin gene.
J. Bacteriol.
169:5095-5100[Abstract/Free Full Text].
|
| 4.
|
Clarke, G. J.,
G. M. Qui,
T. S. Wallis,
W. G. Starkey,
J. Collins,
A. J. Spencer,
S. J. Haddon,
M. P. Osborne,
K. J. Worton, and J. Stephen.
1988.
Expression of an antigen in strains of Salmonella typhimurium which reacts with antibodies to cholera toxin.
J. Med. Microbiol.
25:139-146[Abstract].
|
| 5.
|
Collins, F. M.
1974.
Vaccines and cell-mediated immunity.
Bacteriol. Rev.
38:371-402[Free Full Text].
|
| 6.
|
Collins, F. M.,
G. B. Mackaness, and R. V. Blanden.
1966.
Infection and immunity in experimental salmonellosis.
J. Exp. Med.
124:601-619[Abstract].
|
| 7.
|
Dougan, G.
1994.
Genetics as a route toward mucosal vaccine development, p. 491-506.
In
V. L. Miller, J. B. Kaper, D. A. Portnoy, and R. R. Isberg (ed.), Molecular genetics of bacterial pathogenesis. ASM Press, Washington, D.C.
|
| 8.
|
Finlay, B. B., and S. Falkow.
1990.
Salmonella interaction with polarised human intestinal Caco-2 epithelial cells.
J. Infect. Dis.
162:1096-1106[Medline].
|
| 9.
|
Galan, J. E., and R. Curtiss.
1989.
Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells.
Proc. Natl. Acad. Sci. USA
86:6383-6387[Abstract/Free Full Text].
|
| 10.
|
Galyov, E. E.,
M. W. Wood,
R. Rosqvist,
P. B. Mullan,
P. R. Watson,
S. Hedges, and T. S. Wallis.
1997.
A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa.
Mol. Microbiol.
25:903-912[Medline].
|
| 11.
|
Giannella, R. A.
1979.
Importance of the intestinal inflammatory reaction in salmonella-mediated intestinal secretion.
Infect. Immun.
23:140-145[Abstract/Free Full Text].
|
| 12.
|
Giannella, R. A.,
S. B. Formal,
G. J. Dammin, and J. Collins.
1973.
Pathogenesis of salmonellosis. Studies of fluid secretion, mucosal invasion and morphological reaction in the rabbit ileum.
J. Clin. Investig.
52:441-453.
|
| 13.
|
Giannella, R. A.,
R. E. Gots,
A. N. Charney,
W. B. Greenough, and S. B. Formal.
1975.
Pathogenesis of Salmonella mediated intestinal fluid secretion.
Gastroenterology
69:1238-1245[Medline].
|
| 14.
|
Giannella, R. A.,
W. R. Rout, and S. B. Formal.
1977.
Effect of indomethacin on intestinal water transport in salmonella-infected rhesus monkeys.
Infect. Immun.
17:136-139[Abstract/Free Full Text].
|
| 15.
|
Gots, R. E.,
S. B. Formal, and R. A. Giannella.
1974.
Indomethacin inhibition of Salmonella typhimurium, Shigella flexneri and cholera-mediated rabbit ileal secretion.
J. Infect. Dis.
130:280-284[Medline].
|
| 16.
|
Hoiseth, S. K., and B. A. Stocker.
1981.
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.
Nature
291:238-239[Medline].
|
| 17.
|
Hone, D. M.,
A. M. Harris,
S. Chatfield,
G. Dougan, and M. M. Levine.
1991.
Construction of genetically defined double aro mutants of Salmonella typhi.
Vaccine
9:810-816[Medline].
|
| 18.
|
Hook, E. W.
1988.
Salmonella species (including typhoid fever), p. 1256.
In
G. L. Mandell, R. G. Douglas, and J. E. Bennett (ed.), Principles and practice of infectious diseases, 2nd ed. Churchill Livingstone, London, England.
|
| 19.
|
Hormaeche, C. E.,
A. C. M. Khan,
P. Mastroeni,
B. Villareal,
G. Dougan,
M. Roberts, and S. N. Chatfield.
1994.
Salmonella vaccines: mechanisms of immunity and their use as carriers of recombinant antigens, p. 119-153.
In
D. Ala'Aldeen, and C. E. Hormaeche (ed.), Molecular and clinical aspects of bacterial vaccine development. John Wiley, Chichester, England.
|
| 20.
|
Hornick, R. B.,
S. E. Greisman,
T. E. Woodward,
H. L. DuPont,
A. T. Dawkins, and M. J. Snyder.
1970.
Typhoid fever: pathogenesis and immunologic control.
N. Engl. J. Med.
283:686-691.
|
| 21.
|
Hornick, R. B.,
S. E. Greisman,
T. E. Woodward,
H. L. DuPont,
A. T. Dawkins, and M. J. Snyder.
1970.
Typhoid fever: pathogenesis and immunological control. 2.
N. Engl. J. Med.
283:739-746.
|
| 22.
|
Jepson, M. A.,
C. B. Collares-Buzato,
M. A. Clark,
B. H. Hirst, and N. L. Simmons.
1995.
Rapid disruption of epithelial barrier function by Salmonella typhimurium is associated with structural modification of intercellular junctions.
Infect. Immun.
63:356-359[Abstract].
|
| 23.
|
Khan, S. A.,
P. Everest,
S. Servos,
N. Foxwell,
U. Zahringer,
H. Brade,
E. T. Rietschel,
G. Dougan,
I. G. Charles, and D. J. Maskell.
1998.
A lethal role for lipid A in Salmonella infections.
Mol. Microbiol.
29:571-579[Medline].
|
| 24.
|
Mastroeni, P.,
B. Villareal, and C. E. Hormaeche.
1992.
Role of T-cells, TNF and IFN in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro Salmonella vaccines.
Microb. Pathog.
13:477-491[Medline].
|
| 25.
|
Miles, A. A.,
S. S. Misra, and J. O. Irwin.
1938.
The estimation of the bactericidal action of the blood.
J. Hyg. Camb.
38:732-749.
|
| 26.
|
Mills, D. M.,
V. Bajaj, and C. A. Lee.
1995.
A 40 kb chromosomal fragment encoding Salmonella typhimurium invasion genes is absent from the corresponding region of the E. coli K12 chromosome.
Mol. Microbiol.
15:749-759[Medline].
|
| 27.
|
O'Callaghan, D.,
D. Maskell,
F. Y. Liew,
C. S. F. Easmon, and G. Dougan.
1988.
Characterization of aromatic- and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability to induce protective immunity in BALB/c mice.
Infect. Immun.
56:419-423[Abstract/Free Full Text].
|
| 28.
|
Roberts, M.,
S. N. Chatfield, and G. Dougan.
1994.
Salmonella as carriers of heterologous antigens, p. 27-58.
In
D. T. O'Hagan (ed.), Novel delivery systems for oral vaccines. CRC Press, Boca Raton, Fla.
|
| 29.
|
Shea, J. E.,
M. Hensel,
C. Gleeson, and D. W. Holden.
1996.
Identification of of a virulence locus encoding a second type III secretion system in Salmonella typhimurium.
Proc. Natl. Acad. Sci. USA
93:2593-2597[Abstract/Free Full Text].
|
| 30.
|
Stephen, J.,
T. S. Wallis,
W. G. Starkey,
D. C. A. Candy,
M. P. Osborne, and S. Haddon.
1985.
Salmonellosis: in retrospect and prospect.
Ciba Found. Symp.
112:175-192[Medline].
|
| 31.
|
Stephen, J.,
I. Amin, and G. R. Douce.
1993.
Experimental Salmonella typhimurium-induced gastroenteritis, p. 199-209.
In
F. Cabello, C. Hormaeche, P. Mastreoni, and L. Bonina (ed.), Biology of Salmonella. Plenum Press, New York, N.Y.
|
| 32.
|
Stocker, B. A. D.
1988.
Auxotrophic Salmonella typhi as a live vaccine.
Vaccine
6:141-145[Medline].
|
| 33.
|
Tacket, C., and M. M. Levine.
1994.
Typhoid vaccines old and new, p. 155-178.
In
D. Ala'Aldeen, and C. E. Hormaeche (ed.), Molecular and clinical aspects of bacterial vaccine development. John Wiley, Chichester, England.
|
| 34.
|
Takeuchi, A.
1967.
Electron microscope studies of experimental Salmonella infection. 1. Penetration into the intestinal epithelium by Salmonella typhimurium.
Am. J. Pathol.
50:109-136[Medline].
|
| 35.
|
Vancott, J. L.,
H. F. Staats,
D. W. Pascual,
M. Roberts,
S. N. Chatfield,
M. Yamamoto,
M. Coste,
P. B. Carter,
H. Kiyono, and J. R. McGhee.
1996.
Regulation of mucosal and systemic antibody responses by T helper subsets, macrophages, and derived cytokines following oral immunisation with live recombinant Salmonella.
J. Immunol.
156:1504-1514[Abstract].
|
| 36.
|
Wallis, T. S.,
R. J. H. Hawker,
D. C. A. Candy,
G.-M. Qui,
G. J. Clarke,
K. J. Worton,
M. P. Osborne, and J. Stephen.
1989.
Quantification of the leucocyte influx into rabbit ileal loops induced by strains of Salmonella typhimurium of different virulence.
J. Med. Microbiol.
30:149-156[Abstract].
|
| 37.
|
Wallis, T. S.,
W. G. Starkey,
J. Stephen,
S. J. Haddon,
M. P. Osbourne, and D. C. A. Candy.
1986.
The nature and role of mucosal damage in relation to Salmonella typhimurium-induced fluid secretion in the rabbit ileum.
J. Med. Microbiol.
22:39-49[Abstract].
|
| 38.
|
Watson, P. R.,
S. M. Paulin,
A. P. Bland,
P. W. Jones, and T. S. Wallis.
1995.
Characterization of intestinal invasion by Salmonella typhimurium and Salmonella dublin and effect of a mutation in the invH gene.
Infect. Immun.
63:2743-2754[Abstract].
|
| 39.
|
Watson, P. R.,
E. E. Galyov,
S. M. Paulin,
P. W. Jones, and T. S. Wallis.
1998.
Mutation of invH, but not stn, reduces Salmonella-induced enteritis in cattle.
Infect. Immun.
66:1432-1438[Abstract/Free Full Text].
|
| 40.
|
Worton, K. J.,
D. C. A. Candy,
T. S. Wallis,
G. J. Clarke,
M. P. Osbourne,
S. J. Haddon, and J. Stephen.
1989.
Studies on early association of Salmonella typhimurium with intestinal mucosa in vivo and in vitro: relationship to virulence.
J. Med. Microbiol.
29:283-294[Abstract].
|
Infection and Immunity, June 1999, p. 2815-2821, Vol. 67, No. 6
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.